TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01066052 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT03759379 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT02576158 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT03150914 — Predictive Biomarker (PRD): TSC2
Genes: tuberin; LAM; PPP1R160
Study NCT02001974 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03103256 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00704678 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT00851955 — Predictive Biomarker (PRD): CXCR2 mRNA
Genes: CXCR2; IL8RB
Study NCT03173820 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT03784703 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03784703 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03980431 — Predictive Biomarker (PRD): LAT mRNA
Genes: LAT
Study NCT03774758 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT02747277 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04250168 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04250168 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT04250168 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00774137 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01523340 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01523340 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT01876563 — Predictive Biomarker (PRD): TBP mRNA
Genes: TBP; GTF2D1; TF2D; TFIID
Study NCT00834002 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT03924674 — Surrogate Endpoint (SUR): Serum sodium
Study NCT03881917 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT03881917 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study NCT04769583 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT04170205 — Predictive Biomarker (PRD): 14-3-3 protein sigma
Genes: SFN; HME1
Study NCT04170205 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT04112251 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT04112251 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04112251 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04112251 — Safety Biomarker (SAF): IL-6 and IL-10
Study NCT03159299 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01563731 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01563731 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02357745 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT02932722 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT03169738 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT01184404 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT00044083 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT04053179 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01015313 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04190147 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02718066 — Pharmacodynamic Biomarker (PDY): Histone acetylation
Study NCT02293161 — Pharmacodynamic Biomarker (PDY): Interleukin 7 receptor alpha
Genes: IL7R
Study NCT03185897 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT03853317 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study NCT03853317 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT02888990 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT05022836 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01913210 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02442856 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01501656 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03451578 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT02195336 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03602430 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT03602430 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04655729 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02217852 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02224456 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01971190 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01971190 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01354457 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT03389386 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT01893203 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study NCT02201251 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02652065 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT03012009 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study NCT03909646 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study NCT04877899 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT03630666 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT01983826 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03622203 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study NCT03603392 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01876862 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02958462 — Predictive Biomarker (PRD): PAFAH1B1 mRNA
Genes: PAFAH1B1; LIS1; MDCR; MDS; PAFAHA
Study NCT04478266 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04478266 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04478266 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03602820 — Predictive Biomarker (PRD): RPE65 mRNA
Genes: RPE65
Study NCT00191269 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study NCT00632879 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00632879 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00632879 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03457818 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01955239 — Pharmacodynamic Biomarker (PDY): Salivary secretion
Study NCT00279448 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT00579137 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study NCT00579137 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study NCT02202525 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03168074 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT03168074 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00261456 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT00261456 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT00261456 — Predictive Biomarker (PRD): MLH1 mRNA
Genes: MLH1; COCA2
Study NCT00261456 — Predictive Biomarker (PRD): DNA mismatch repair protein MSH2
Genes: MSH2
Study NCT01684852 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03081715 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02620657 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04579926 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04531735 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00919581 — Predictive Biomarker (PRD): MIF mRNA
Genes: MIF; GLIF; MMIF
Study NCT04760821 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT01433536 — Predictive Biomarker (PRD): ALK
Genes: CD246; ALK1
Study NCT00314691 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT01171417 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT00981240 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00194740 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01978678 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT02546908 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT00996190 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00697775 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study NCT01621490 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01621490 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT03185988 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04215796 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT00346762 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01121172 — Predictive Biomarker (PRD): APLNR mRNA
Genes: APLNR; AGTRL1; APJ
Study NCT01080742 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00629759 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03800407 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT04359667 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00125359 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00274703 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT02535650 — Predictive Biomarker (PRD): HRAS mRNA
Genes: HRAS; HRAS1
Study NCT02535650 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT02535650 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study NCT02535650 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT04169568 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00685542 — Safety Biomarker (SAF): Interleukin 1
Study NCT00383370 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01368003 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT00325403 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04078035 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT04078035 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04078035 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04382391 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00414271 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT00414271 — Predictive Biomarker (PRD): TYMS
Genes: Tsase; TMS; HsT422
Study NCT03232203 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT04296890 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT01088529 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT01605071 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02223312 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02223312 — Predictive Biomarker (PRD): TAPBP mRNA
Genes: TAPBP; NGS17; TAPA
Study NCT02223312 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01896050 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01543464 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT01543464 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02951611 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02951611 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT04399889 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00082979 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT00082979 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01117077 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01117077 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study NCT02119078 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03939026 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03939026 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study NCT02196857 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT00820352 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT02170857 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00000589 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study NCT04673968 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT03039452 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT03039452 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03344601 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT03460275 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03998930 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study NCT00219739 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00219739 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT04879316 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00641758 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT02104752 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT00666172 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03344822 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03760055 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00889408 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00889408 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT02841267 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Growth/differentiation factor 8
Genes: MSTN; GDF8
Study NCT04724785 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02764333 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02764333 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT02161861 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT01025531 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study NCT03570203 — Surrogate Endpoint (SUR): Serum sodium
Study NCT03709147 — Safety Biomarker (SAF): Serine/threonine-protein kinase STK11
Genes: STK11
Study NCT03944603 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00967642 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00178217 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02146222 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT02146222 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT02146222 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02146222 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01548859 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT03784261 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02066675 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT02906202 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02906202 — Predictive Biomarker (PRD): HBB mRNA
Genes: HBB
Study NCT03034122 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT03933332 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04348643 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT01080651 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT03214978 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT03214978 — Predictive Biomarker (PRD): TTN mRNA
Genes: TTN
Study NCT03434574 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01784848 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01050322 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01050322 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02215330 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT04251611 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02833350 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00570765 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study NCT01860716 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01860716 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT01860716 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01648920 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT00090870 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04624854 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study NCT04624854 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT02437383 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT02284269 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT03505554 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04137627 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study NCT04137627 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-210
Genes: MIR210
Study NCT01516203 — Monitoring Biomarker (MOI): M. tuberculosis 85B mRNA
Genes: fbpB; Rv1886c; MTCY180.32
Study NCT02208570 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02324972 — Predictive Biomarker (PRD): INPP5D mRNA
Genes: INPP5D; SHIP; SHIP1
Study NCT00135707 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00135707 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01232777 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03373071 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01408901 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03382418 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04225013 — Predictive Biomarker (PRD): PDXP mRNA
Genes: PDXP; CIN; PLP; PLPP
Study NCT04225013 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT00462683 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04496466 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02678689 — Predictive Biomarker (PRD): Tripeptidyl-peptidase I
Genes: TPP1; CLN2; GIG1; UNQ267/PRO304
Study NCT02159716 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study NCT00421174 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04553770 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04553770 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04553770 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03176095 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study NCT03775967 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT02016573 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02389062 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study NCT01517620 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02198872 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT00002773 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04242420 — Predictive Biomarker (PRD): GJA4 mRNA
Genes: GJA4
Study NCT04242420 — Predictive Biomarker (PRD): GJA1 mRNA
Genes: GJA1; GJAL
Study NCT01977209 — Predictive Biomarker (PRD): APEX1 mRNA
Genes: APEX1; APE; APE1; APEX; APX; HAP1; REF1
Study NCT01517243 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00279552 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03235544 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT03212690 — Pharmacodynamic Biomarker (PDY): RAS peptides
Study NCT01595633 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00200577 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01781754 — Predictive Biomarker (PRD): UCP2 mRNA
Genes: UCP2; SLC25A8
Study NCT01781754 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT01403571 — Surrogate Endpoint (SUR): Serum creatinine